Barclays raised the firm’s price target on Emerson (EMR) to $144 from $140 and keeps an Equal Weight rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR:
- Christopher Snyder Initiates Sell on Emerson Amid Cut Growth Outlook and Questionable Second‑Half Reacceleration
- Emerson Electric Earnings Call Highlights Profitable Resilience
- Emerson Electric Posts Strong Q2 Results, Reaffirms 2026 Outlook
- Emerson reports Q2 adjusted EPS $1.54, consensus $1.53
- Emerson sees Q3 adjusted EPS $1.65-$1.70, consensus $1.68